Next, we again resorted to the transcriptome dataset of NPC1 KO brain and liver to determine if any transcription factors in the KLF2 and ETS families were predicted to have increased or decreased activity during NPC disease progression. This evidence concerns the gene KLF2 and nasopharyngeal carcinoma.